Applicant, as named in the Orange Book

Xcovery

Next listed expiry: Ensacove on 1 Jun 2037. 1 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Ensacove · 2 strengths ensartinib hydrochloride	ensartinib hydrochloride	218171	1 Jun 2037	patent

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.